Intermittent fasting has gained traction in the United States as a way to lose weight. Amarasate, a weight-management extract, is being touted as an effective anorexigenic agent for such a diet.
A recent review of astaxanthin found evidence to support the safety of dosages of 12 mg up to 24 mg a day. But that applies to only to natural astaxanthin, not to the synthetic forms, the authors said.
Eggshell membrane could be the key ingredient to help the sufferers of knee pain and stiffness associated with osteoarthritis. Nearly one quarter of US adults struggle with the condition.
Higher levels of the omega-3 fatty acid DHA (docosahexaenoic acid) may be associated with longer sleep duration for Mexican adolescents, suggests a new study.
The American Botanical Council has brought the climate crisis question full circle, with a new article that resists some of the findings from an article on the subject the organization first published a decade ago.
An upcoming webinar will explore the taxonomic changes to the genus Lactobacillus and the implications for brands, from labeling to consumer education.
A leading nutritionist is calling for greater awareness of vitamin D deficiency in younger healthy populations that are becoming susceptible to an increased diabetes risk as a result.
Could an individual’s microbiome indicate how wealthy they are? That is the premise for a team of scientists, who suggest a healthy gut and its microbe profile are linked to social and economic status.
A combination of two Lactobacillus strains may reduce the severity of runny nose, and may reduce absences from day care, says a new study from Swedish probiotic player Probi.
The agreement aims to gather research for product development strategies and solutions and ultimately bring new synbiotic discoveries to the marketplace.
A new study from Dr Pieter Cohen has revealed the presence of piracetam, a drug that is not approved for use by the FDA, in cognitive enhancement products labeled as dietary supplements, strengthening calls by stakeholders for a mandatory product registry...
Nestlé continues to accelerate its efforts in microbiome research as the Swiss multinational announces a partnership with the University of California San Diego Center for Microbiome Innovation (CMI).
Higher blood levels of omega-3 are not associated with an increased risk of prostate cancer, according to new data published last week at the 2019 American Heart Association Scientific Sessions in Philadelphia.
